Price Target Estimates for Lam Research Corporation (LRCX)

Marco Green
December 7, 2017

The company's market cap is $29.59 Billion, and the average volume is 2.33 Million.

In recent action, Lam Research Corporation (LRCX) has made a move of -12.65% over the past month, which has come on Strong relative transaction volume. Lam Research Corporation (NASDAQ:LRCX) has risen 107.86% since December 5, 2016 and is uptrending. It has outperformed by 40.70% the S&P500.

Alex Sacerdote increased its stake in Lam Research Corp (LRCX) by 67.97% based on its latest 2017Q2 regulatory filing with the SEC. Horizon Investment Services Llc sold 3,067 shares as the company's stock rose 32.64% with the market. The company's quarterly EPS surprised Wall Street by as much as 5% to the upside in its last earnings announcement, so investors should note this tendency when assessing consensus estimates.

The stock decreased 5.07% or $0.9 during the last trading session, reaching $16.85. Finally, UBS Asset Management Americas Inc. grew its position in shares of Lam Research by 9.5% in the second quarter. The stock witnessed -6.96% declines, 0.43% gains and 1.6% gains for the 1-month, 3-month and 6-month period, respectively. It turned negative, as 43 investors sold LRCX shares while 255 reduced holdings. 110 funds opened positions while 182 raised stakes. DA Davidson reiterated a "buy" rating on shares of Lam Research in a report on Wednesday, October 18th. Harbour Capital Advisors LLC now owns 1,890,919 shares of the semiconductor company's stock valued at $13,370,000 after acquiring an additional 1,876,544 shares in the last quarter. 1832 Asset Mngmt Limited Partnership has 133,000 shares for 0.09% of their portfolio. Lumbard And Kellner Llc has invested 0.42% of its portfolio in Lam Research Corporation (NASDAQ:LRCX). Comerica Securities accumulated 8,061 shares. Enterprise Financial Svcs Corp has 0.01% invested in Lam Research Corporation (NASDAQ:LRCX) for 106 shares. Archford Capital Strategies Ltd Liability Com invested in 0% or 17,320 shares. Lmr Llp holds 23,130 shares. Commerzbank Aktiengesellschaft Fi invested 0.04% in Lam Research Corporation (NASDAQ:LRCX). They expect $0.94 earnings per share, down 25.40% or $0.32 from last year's $1.26 per share. Mckinley Cap Mgmt Ltd Delaware reported 229,266 shares. Argus initiated coverage on shares of Lam Research in a research report on Tuesday, September 12th. 1,789 were reported by Wetherby Asset. Bb&T Corporation has 0.19% invested in Lam Research Corporation (NASDAQ:LRCX).

Shares of New York Community Bancorp, Inc. It also increased its holding in Cirrus Logic Inc (NASDAQ:CRUS) by 29,707 shares in the quarter, for a total of 37,532 shares, and has risen its stake in Primerica Inc (NYSE:PRI).

Since June 12, 2017, it had 0 insider buys, and 2 insider sales for $1.82 million activity.

Lam Research Corporation has a beta of 0.55, offering the possibility of a higher rate of return, but also posing more risk. Goldman Sachs upgraded Lam Research Corporation (NASDAQ:LRCX) on Monday, December 19 to "Buy" rating. More interesting news about Lam Research Corporation (NASDAQ:LRCX) was released by: and their article: "Lam Research Corporation (LRCX) Ex-Dividend Date Scheduled for December 05, 2017" with publication date: December 04, 2017.

Out of 6 Wall Street analysts rating Lam Research, 5 give it "Buy", 0 "Sell" rating, while 1 recommend "Hold". Therefore 86% are positive.

17 analysts on average are expecting the company to report revenue of $2.32 Billion for the current quarter. The company was maintained on Thursday, October 20 by Needham.

Lam Research Corporation (LRCX) saw 798.24 million in free cash flow last quarter, representing a quarterly net change in cash of 28.93 million. The stock's last price was higher from the average trading price of 50 days recorded at $12.79 while enlarging the period to 200 trading days, the average price was $13.11. Zacks Investment Research lowered Lam Research from a "buy" rating to a "hold" rating in a report on Tuesday, March 21st. The company was maintained on Wednesday, October 18 by KeyBanc Capital Markets.

The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. Manchester Capital Ltd Limited Liability Company reported 0.03% in Lam Research Corporation (NASDAQ:LRCX). Comparatively, LRCX posted earnings of $0 per share in the same quarter, a year earlier. LRCX's profit will be $594.34 million for 12.30 P/E if the $3.67 EPS becomes a reality. "Ultimately, through all this investigation into the company's performance the analyst decides if their stock is a "buy", sell" or hold".

Analysts await Valeant Pharmaceuticals International, Inc. The firm has "Buy" rating by Needham given on Thursday, July 27. Mizuho maintained the shares of IRWD in report on Friday, November 4 with "Buy" rating. Also, Director Stephen G. Newberry sold 750 shares of the stock in a transaction that occurred on Monday, September 11th.

Other reports by Click Lancashire

Discuss This Article